{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:58:07Z","timestamp":1789095487650,"version":"build-2803163510"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T00:00:00Z","timestamp":1617926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012615","name":"University of Texas Health Science Center at Houston","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012615","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Tuberous sclerosis complex (TSC) is a genetic condition that causes benign tumors to grow in multiple organ systems. Nonfunctional pancreatic neuroendocrine tumors (PNETs) are a rare clinical feature of TSC with no specific guidelines outlined for clinical management at this time. Our purpose is to calculate the frequency of nonfunctional PNETs as well as characterize the presentation, current clinical management, and assess the impact of systemic mammalian target of rapamycin (mTOR) on nonfunctional PNETs in TSC.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> This retrospective chart review was performed by a query of the TS Alliance's Natural History Database and the Cincinnati Children's Hospital TSC Database for patients with nonfunctional PNET. Clinical data from these two groups was summarized for patients identified to have a nonfunctional PNET and compared to previously reported cases with TSC and nonfunctional PNETs.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Our calculated frequency of nonfunctional PNETs is 0.65%. We identified 16 individuals, nine males and seven females, with a median age of 18.0 years (interquartile range: \u221215.5 to 25.5). Just over half (56.3%, <jats:italic>n<\/jats:italic> = 9) of the patients provided results from genetic testing. Six had pathogenic variants in <jats:italic>TSC2<\/jats:italic> whereas three had pathogenic variants in <jats:italic>TSC1<\/jats:italic>. The average age at PNET diagnosis was 15.0 years (range: 3\u201346 years). Almost all individuals were diagnosed with a PNET during routine TSC surveillance, 56.3% (<jats:italic>n<\/jats:italic> = 9) by MRI, 12.5% (<jats:italic>n<\/jats:italic> = 2) by CT, 25% (<jats:italic>n<\/jats:italic> = 4) by ultrasound, and 6.2% (<jats:italic>n<\/jats:italic> = 1) through a surgical procedure. Follow up after diagnosis involved 68.8% (<jats:italic>n<\/jats:italic> = 11) having serial imaging and nine of the sixteen individuals proceeding with surgical removal of the PNET. Eight individuals had a history of using systemic mTOR inhibitors. Tumor growth rate was slightly less in individuals taking an mTOR inhibitor (\u22120.8 mm\/yr, IQR: \u22122.3 to 2.2) than those without (1.6 mm\/yr; IQR: \u22120.99 to 5.01, <jats:italic>p<\/jats:italic> &amp;gt; 0.05).<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> Nonfunctional PNETs occurred at younger ages in our TSC cohort and more commonly compared to ages and prevalence reported for the general population. PNETs in patients on systemic mTOR inhibitors had lower rates of growth. The outcome of this study provides preliminary evidence supporting the use of mTOR inhibitor therapy in conjunction with serial imaging as medical management for nonfunctional PNETs as an alternative option to invasive surgical removal.<\/jats:p>","DOI":"10.3389\/fneur.2021.627672","type":"journal-article","created":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T05:37:30Z","timestamp":1617946650000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Frequency, Progression, and Current Management: Report of 16 New Cases of Nonfunctional Pancreatic Neuroendocrine Tumors in Tuberous Sclerosis Complex and Comparison With Previous Reports"],"prefix":"10.3389","volume":"12","author":[{"given":"Kate","family":"Mowrey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hope","family":"Northrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peyton","family":"Rougeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Shahrukh","family":"Hashmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darcy A.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ebrahimi-Fakhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Towbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"Trout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie K.","family":"Capal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Neal","family":"Franz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rodriguez-Buritica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-018-0870-y","article-title":"Incidence of tuberous sclerosis and age at first diagnosis: new data and emerging trends from a national, prospective surveillance study","volume":"13","author":"Ebrahimi-Fakhari","year":"2018","journal-title":"Orphanet J Rare Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","article-title":"Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Krueger","year":"2013","journal-title":"Pediatr Neurol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/sj.ejhg.5201402","article-title":"Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype-phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex","volume":"13","author":"Sancak","year":"2005","journal-title":"Eur J Hum Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","article-title":"Identification and characterization of the tuberous sclerosis gene on chromosome 16","volume":"75","year":"1993","journal-title":"Cell."},{"key":"B5","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.277.5327.805","article-title":"Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34","volume":"277","author":"van Slegtenhorst","year":"1997","journal-title":"Science."},{"key":"B6","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/GIM.0b013e31803068c7","article-title":"Genotype\/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States","volume":"9","author":"Au","year":"2007","journal-title":"Genet Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.4158\/EP13010.CR","article-title":"Pancreatic neuroendocrine tumor in a child with a tuberous sclerosis complex 2 (TSC2) mutation","volume":"19","author":"Bombardieri","year":"2013","journal-title":"Endocr Pract."},{"key":"B8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s10689-017-0029-3","article-title":"Pancreatic neuroendocrine tumor in a patient with a TSC1 variant: case report and review of the literature","volume":"17","author":"Mortaji","year":"2018","journal-title":"Familial Cancer."},{"key":"B9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00247-016-3701-0","article-title":"Pancreatic tumors in children and young adults with tuberous sclerosis complex","volume":"47","author":"Koc","year":"2017","journal-title":"Pediatr Radiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1210\/js.2019-00051","article-title":"Pancreatic neuroendocrine tumor in a young child with tuberous sclerosis complex 1","volume":"3","author":"Mehta","year":"2019","journal-title":"J Endocr Soc."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e227292","DOI":"10.1136\/bcr-2018-227292","article-title":"Interesting pancreatic tumour in the background of tuberous sclerosis","volume":"12","author":"Amarjothi","year":"2019","journal-title":"BMJ Case Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1093\/annonc\/mdn351","article-title":"Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival","volume":"19","author":"Halfdanarson","year":"2008","journal-title":"Ann Oncol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1148\/rg.2020200025","article-title":"Pancreatic neuroendocrine neo-plasms: 2020 update on pathologic and imaging findings and classification","volume":"40","author":"Khanna","year":"2020","journal-title":"Radiographics."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ecl.2010.12.005","article-title":"The epidemiology of gastroenteropancreatic neuroendocrine tumors","volume":"40","author":"Lawrence","year":"2011","journal-title":"Endocrinol Metab Clin North Am."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u201ccarcinoid:\u201d epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1053\/j.gastro.2008.05.047","article-title":"Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors","volume":"135","author":"Metz","year":"2008","journal-title":"Gastroenterology."},{"key":"B18","article-title":"Multiple endocrine neoplasia type 1","volume-title":"GeneReviews","author":"Giusti","year":"2005"},{"key":"B19","unstructured":"NishiT\n            KawabataY\n            HariY\n            ImaokaH\n            IshikawaN\n            YanoS\n          22824559A Case of Pancreatic Neuroendocrine Tumor in a Patient with Neurofibromatosis-12012"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1002\/cncr.23648","article-title":"Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies","volume":"113","author":"Jensen","year":"2008","journal-title":"Cancer."},{"key":"B21","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1159\/000079616","article-title":"Hereditary pancreatic endocrine tumours","volume":"4","author":"Alexakis","year":"2004","journal-title":"Pancreatology."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1210\/jc.2018-00259","article-title":"High fear of disease occurrence is associated with low quality of life in patients with multiple endocrine neoplasia type 1: results from the Dutch MEN1 Study Group","volume":"103","author":"van Leeuwaarde","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"key":"B23","doi-asserted-by":"publisher","first-page":"853","DOI":"10.2217\/fon.14.285","article-title":"Pancreatic neuroendocrine tumors: a review","volume":"11","author":"Young","year":"2015","journal-title":"Future Oncol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000443171","article-title":"E-mail ENETS consensus guidelines ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors","volume":"103","author":"Falconi","year":"2016","journal-title":"Neuroendocrinology."},{"key":"B25","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1001\/archsurg.142.4.347","article-title":"Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms: The Massachusetts General Hospital experience from 1977 to 2005","volume":"142","author":"Vagefi","year":"2007","journal-title":"Archiv Surg."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1245\/s10434-012-2285-7","article-title":"Incidental detection of pancreatic neuroendocrine tumors: an analysis of incidence and outcomes","volume":"19","author":"Cheema","year":"2012","journal-title":"Ann Surg Oncol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.suc.2014.02.010","article-title":"Nonfunctional pancreatic neuroendocrine tumors","volume":"94","author":"Kuo","year":"2014","journal-title":"Surg Clin North Am."},{"key":"B28","doi-asserted-by":"publisher","first-page":"598438","DOI":"10.3389\/fmed.2020.598438","article-title":"Management of asymptomatic sporadic nonfunctioning pancreatic neuroendocrine neoplasms (ASPEN) \u22642 cm: study protocol for a prospective observational study","volume":"7","author":"Partelli","year":"2020","journal-title":"Front Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1002\/ajmg.a.31351","article-title":"Extensive acrochordons and pancreatic islet-cell tumors in tuberous sclerosis associated with TSC2 mutations","volume":"140","author":"Merritt","year":"2006","journal-title":"Am J Med Genet Part A."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1097\/00000478-200310000-00012","article-title":"Malignant pancreatic endocrine tumor in a child with tuberous sclerosis","volume":"27","author":"Francalanci","year":"2003","journal-title":"Am J Surg Pathol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/PAS.0b013e31823d0560","article-title":"Well-differentiated pancreatic neuroendocrine carcinoma in tuberous sclerosis\u2013case report and review of the literature","volume":"36","author":"Arva","year":"2012","journal-title":"Am J Surg Pathol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1177\/1066896911428735","article-title":"Neuroendocrine tumor of the pancreas in a patient with tuberous sclerosis: A case report and review of the literature","volume":"20","author":"D\u00edaz","year":"2012","journal-title":"Int J Surg Pathol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jpedsurg.2011.11.046","article-title":"Malignant pancreatic tumors in children: a single-institution series","volume":"47","author":"van den Akker","year":"2012","journal-title":"J Pediatr Surg."},{"key":"B34","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/j.1399-0004.2011.01805.x","article-title":"Pancreatic neuroendocrine tumors in patients with tuberous sclerosis complex Nothing to declare","volume":"82","author":"Larson","year":"2012","journal-title":"Clin Genet."},{"key":"B35","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1136\/jcp.37.3.272","article-title":"Tuberous sclerosis: unusual associations in four cases","volume":"37","author":"Ilgren","year":"1984","journal-title":"J Clin Pathol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s004310051073","article-title":"Malignant pancreatic tumour within the spectrum of tuberous sclerosis complex in childhood","volume":"158","author":"Verhoef","year":"1999","journal-title":"Eur J Pediatr."},{"key":"B37","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1677\/ERC-08-0142","article-title":"Are neuroendocrine tumours a feature of tuberous sclerosis? A systematic review","volume":"16","author":"Dworakowska","year":"2009","journal-title":"Endocr Relat Cancer."},{"key":"B38","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4158\/ep.8.2.109","article-title":"Insulinoma in a patient with tuberous sclerosis: is there an association?","volume":"8","author":"Eledrisi","year":"2002","journal-title":"Endocrine Practice."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/SLA.0000000000000856","article-title":"Long-term prognosis of resected pancreatic neuroendocrine tumors in von Hippel-Lindau disease is favorable and not influenced by small tumors left in place","volume":"262","author":"de Mestier","year":"2015","journal-title":"Ann Surg."},{"key":"B41","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.prp.2008.04.008","article-title":"Malignant epithelioid angiomyolipoma of the kidney in a patient with tuberous sclerosis: an autopsy case report with p53 gene mutation analysis","volume":"204","author":"Sato","year":"2008","journal-title":"Pathol Res Pract."},{"key":"B42","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1572-0241.2006.00367.x","article-title":"Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1","volume":"101","author":"Thomas-Marques","year":"2006","journal-title":"Am J Gastroenterol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/01.sla.0000197715.96762.68","article-title":"Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas","volume":"243","author":"Triponez","year":"2006","journal-title":"Ann Surg."},{"key":"B44","unstructured":"KunzPL\n            Reidy-LagunesD\n            AnthonyLB\n            BertinoEM\n            BrendtroK\n            ChanJA\n          23591432Consensus Guidelines for the Management and Treatment of Neuroendocrine Tumors2013"},{"key":"B45","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1097\/MPA.0b013e318212c42d","article-title":"A unique case of a nonfunctional metastatic pancreatic neuroendocrine tumor transforming into an insulin-secreting tumor with an unusual clinical course","volume":"40","author":"Vashi","year":"2011","journal-title":"Pancreas."},{"key":"B46","doi-asserted-by":"publisher","first-page":"232470961247327","DOI":"10.1177\/2324709612473274","article-title":"Metastatic insulinoma following resection of nonsecreting pancreatic islet cell tumor","volume":"1","author":"Koshy","year":"2013","journal-title":"J Investig Med High Impact Case Rep."},{"key":"B47","doi-asserted-by":"publisher","first-page":"150032","DOI":"10.1530\/edm-15-0032","article-title":"Pancreatic neuroendocrine tumors with transformation to insulinoma: an unusual presentation of a rare disease","volume":"2015","author":"Nahmias","year":"2015","journal-title":"Endocrinol Diabetes Metab Case Rep."},{"key":"B48","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1590\/2359-3997000000049","article-title":"Transformation of nonfunctioning pancreatic tumor into malignant insulinoma after 3 years: an uncommon clinical course of insulinoma","volume":"59","author":"Sayki Arslan","year":"2015","journal-title":"Arch Endocrinol Metab."},{"key":"B49","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3390\/ijms19030747","article-title":"The role of mTOR in neuroendocrine tumors: future cornerstone of a winning strategy?","volume":"19","author":"Lamberti","year":"2018","journal-title":"Int J Mol Sci."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.627672\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T05:37:33Z","timestamp":1617946653000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.627672\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,9]]},"references-count":49,"alternative-id":["10.3389\/fneur.2021.627672"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.627672","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,9]]},"article-number":"627672"}}